Synergo for Bladder Cancer

Synergo for Bladder Cancer Synergo® is an advanced technology for the treatment of non-muscle invasive bladder cancer: local microwave (RF) induced hyperthermia with chemotherapy

We look forward to seeing you at the upcoming EAU congress in London, UK and invite you to visit us at Booth R21
29/01/2026

We look forward to seeing you at the upcoming EAU congress in London, UK and invite you to visit us at Booth R21

As the year comes to a close, we would like to extend our sincere thanks for your continued trust and collaboration. We ...
24/12/2025

As the year comes to a close, we would like to extend our sincere thanks for your continued trust and collaboration. We wish you a joyful holiday season and a healthy, successful New Year.

19/11/2025

Thrilled to see this new real-world evidence using RITE + intravesical MMC in NMIBC.
A heartfelt thank you to Prof. Shahrokh F. Shariat, Assoc. Prof. (Priv.-Doz.) Dr. David D’Andrea, Dr. Elisabeth Grobet-Jeandin, and the rest of the team for their important work with the device.
As the authors conclude:
“RITE resulted in notable antitumor activity and allows for the avoidance of more aggressive and quality-of-life-limiting therapies, such as radical cystectomy.”
Highlights at 24 months in a challenging patient group (including BCG failures, those ineligible for BCG or cystectomy): high-grade recurrence-free survival of ~74.8% and cystectomy-free survival of 93.8%.
Thank you for advancing bladder-sparing options and giving more patients hope for less invasive, quality-of-life-preserving care. 🙏
S. Mero, K. Oberneder, J. Weiss, E. Grobet-Jeandin, A. Grégoris, P. Sèbe, S. Shariat, D. D’Andrea,
Hipertermia inducida por radiofrecuencia en el cáncer de vejiga no músculo invasor: resultados oncológicos en un escenario real,Actas Urológicas Españolas, Volume 49, Issue 5, 2025, 501746,
ISSN 0210-4806
;

May marks Bladder Cancer Awareness Month — an opportunity to raise awareness about a common, yet sometimes overlooked, d...
05/05/2025

May marks Bladder Cancer Awareness Month — an opportunity to raise awareness about a common, yet sometimes overlooked, disease.
Bladder cancer is the ninth most common cancer worldwide and the fourth most common in men. Men are affected four times more than women.
Over 600,000 new cases are diagnosed each year, and around 1.9 million people are currently living with the disease.

Explore Synergo for NMIBC treatment. Maximize results with RF, chemo, and hyperthermia. Visit us at the upcoming EAU ann...
04/02/2025

Explore Synergo for NMIBC treatment. Maximize results with RF, chemo, and hyperthermia. Visit us at the upcoming EAU annual conference in Madrid!

Adres

147A Amsterdamseweg
Amstelveen
1182GT

Telefoon

+31(0)206423719

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Synergo for Bladder Cancer nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar Synergo for Bladder Cancer:

Snelkoppelingen

Uitgelicht

Delen